Bridging the gap in your Phase I clinical studies. 

The pharmaceutical market in Japan holds the second-largest position globally. To meet the healthcare demands of its population, Japan heavily depends on the import of pharmaceutical products. In order to leverage these opportunities, drug developers must adhere to the rigorous regulations set by the Pharmaceuticals and Medical Devices Agency (PMDA).

Richmond Pharmacology possesses the necessary expertise to assist you in bridging the gap for your upcoming Phase I clinical study.

x

Learn about the bridging studies conducted at Richmond Pharmacology

A single centre study for Chiesi Pharmaceuticals. 16 Japanese and 16 Caucasian volunteers participated in cross over, bridging study for Chronic obstructive pulmonary disease. Read about our approach and the controls we introduced to reduce variability. Learn more here.

A cognitive function profile of a second generation antihistamine. The effect of rupatadine on cognitive functioning was evaluated by means of computerized cognitive tests: rapid visual information processing (RVP), reaction time (RT), spatial working memory (SWM) and visual analogue scales (VAS) with 27 Japanese volunteers. Learn more here.

Why Richmond Pharmacology

TAP OR CLICK A BLOCK BELOW TO LEARN MORE

Expertise in PMDA criteria

We have conducted more than 100 ethnic bridging studies enabling us to build a trusted relationship with the PMDA.

Read more +

20,000 active 1st generation Japanese subjects

Our recruitment database is the largest in Europe with more than 20,000 active 1st generation Japanese subjects. 

Read more +

Short- and long-term residency periods

We can accommodate studies with short-term and long-term residency periods.

Read more +

Richmond Pharmacology's ethnic bridging studies will reduce the PMDA approval timeline and accelerate your time to market.

Fast track your global marketing approvals

Our expertise can help you accelerate your drug development timelines globally

Get in touch today

Latest news

Engaging Hearts and Hands: A Day of Volunteering at Arc Nursery

September 12, 2023
Discover how Richmond's dedicated team of volunteers is making a positive impact on young minds at Arc Nursery
Read more

Exciting Research Update: Enhancing Blinding in Clinical Trials with Auto-Injectors

September 5, 2023
We’re excited to share the findings of our recent study on the use of auto-injector systems (A-INJ) in randomized controlled trials (RCTs) by Dr Jorg Taubel, Dr Ulrike Lorch, Dr Thomas York and Vishal Aggarwal.
Read more

Events

BioJapan 2023

11-13 October 2023
BioJapan is "Asia's largest partnering event consisting of Exhibition, Seminar, and Partnering program".
View event